| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Humeau Laurent | Chief Scientific Officer | C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE RD., SAN DIEGO | /s/ Laurent Humeau | 05 Mar 2026 | 0001770390 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INO | Common Stock Option | Award | +26,840 | $0.000000* | 26,840 | 04 Mar 2026 | Common Stock | 26,840 | $1.73 | Direct | F1 | ||
| transaction | INO | Restricted Stock Unit | Award | +21,560 | $0.000000* | 21,560 | 04 Mar 2026 | Common Stock | 21,560 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |